๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Miro Sciences Ltd (ASX:MSX)
Australia flag Australia ยท Delayed Price ยท Currency is AUD
0.0430
0.00 (0.00%)
Nov 19, 2026, 2:59 PM AEDT

Miro Sciences Earnings Call Transcripts

Fiscal Year 2026

  • Status update

    Four out of five patients with fistulizing Crohn's disease showed strong clinical response to StemSmart in a Special Access Program, prompting two phase II trials to launch by year-end. The therapy is safe, systemically administered, and targets a major unmet need in Crohn's, with global commercialization and regulatory milestones underway.

Fiscal Year 2025

  • Investor Update

    A new stem cell platform was acquired, shifting focus to Crohn's disease and other high-value indications. Early clinical data is strong, with a special access program underway and phase two trials planned. Manufacturing and advisory partnerships de-risk development and support future expansion.